Abstract PR006: Patient-level prediction of trial outcomes with a calibrated pan-cancer foundation model
A calibrated pan-cancer foundation model integrating patient-level RWD with summary-level clinical trial outcomes and fine-tuned on data to support tailored predictions across biomarkers, indications, and treatments is developed.